Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
Saved in:
| Title: | Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer. |
|---|---|
| Authors: | Eke I; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Zscheppang K; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Dickreuter E; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Hickmann L; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Mazzeo E; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Unger K; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Krause M; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC)., Cordes N; OncoRay, National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (IE, KZ, ED, LH, EM, MK, NC); Department of Radiation Oncology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany (IE, MK, NC); Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (KZ); Research Unit Radiation Cytogenetics, Helmholtz-Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (KU); Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz-Zentrum München, Neuherberg, Germany (KU); German Cancer Consortium (DKTK), Dresden, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany (MK, NC); Institute of Radiooncology, Helmholtz-Zentrum Dresden, Rossendorf, Dresden, Germany (MK, NC). nils.cordes@oncoray.de. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Feb 05; Vol. 107 (2). Date of Electronic Publication: 2015 Feb 05 (Print Publication: 2015). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
